Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Aug 9, 2021
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2021-08-05$43.15/sh+23,640$1,020,054→ 32,440 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $42.66 USD to $43.46 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.